Literature DB >> 23241648

Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.

Tristan J Watkins1, Vidya Raj, Junghee Lee, Mary S Dietrich, Aize Cao, Jennifer U Blackford, Ronald M Salomon, Sohee Park, Margaret M Benningfield, Christina R Di Iorio, Ronald L Cowan.   

Abstract

RATIONALE: Ecstasy (3,4-methylenedioxymethamphetamine [MDMA]) polydrug users have verbal memory performance that is statistically significantly lower than that of control subjects. Studies have correlated long-term MDMA use with altered brain activation in regions that play a role in verbal memory.
OBJECTIVES: The aim of our study was to examine the association of lifetime ecstasy use with semantic memory performance and brain activation in ecstasy polydrug users.
METHODS: A total of 23 abstinent ecstasy polydrug users (age = 24.57 years) and 11 controls (age = 22.36 years) performed a two-part functional magnetic resonance imaging (fMRI) semantic encoding and recognition task. To isolate brain regions activated during each semantic task, we created statistical activation maps in which brain activation was greater for word stimuli than for non-word stimuli (corrected p < 0.05).
RESULTS: During the encoding phase, ecstasy polydrug users had greater activation during semantic encoding bilaterally in language processing regions, including Brodmann areas 7, 39, and 40. Of this bilateral activation, signal intensity with a peak T in the right superior parietal lobe was correlated with lifetime ecstasy use (r s = 0.43, p = 0.042). Behavioral performance did not differ between groups.
CONCLUSIONS: These findings demonstrate that ecstasy polydrug users have increased brain activation during semantic processing. This increase in brain activation in the absence of behavioral deficits suggests that ecstasy polydrug users have reduced cortical efficiency during semantic encoding, possibly secondary to MDMA-induced 5-HT neurotoxicity. Although pre-existing differences cannot be ruled out, this suggests the possibility of a compensatory mechanism allowing ecstasy polydrug users to perform equivalently to controls, providing additional support for an association of altered cerebral neurophysiology with MDMA exposure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23241648      PMCID: PMC3615064          DOI: 10.1007/s00213-012-2936-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  68 in total

Review 1.  MDMA use and neurocognition: a meta-analytic review.

Authors:  Ari D Kalechstein; Richard De La Garza; James J Mahoney; William E Fantegrossi; Thomas F Newton
Journal:  Psychopharmacology (Berl)       Date:  2006-11-03       Impact factor: 4.530

2.  Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study.

Authors:  John Karageorgiou; Mary S Dietrich; Evonne J Charboneau; Neil D Woodward; Jennifer U Blackford; Ronald M Salomon; Ronald L Cowan
Journal:  Neuroimage       Date:  2009-03-02       Impact factor: 6.556

Review 3.  MDMA: historical perspectives.

Authors:  J W Gibb; M Johnson; D Stone; G R Hanson
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

4.  Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.

Authors:  A C Parrott; T Buchanan; A B Scholey; T Heffernan; J Ling; J Rodgers
Journal:  Hum Psychopharmacol       Date:  2002-08       Impact factor: 1.672

Review 5.  Brain serotonin function in MDMA (ecstasy) users: evidence for persisting neurotoxicity.

Authors:  Margaret M Benningfield; Ronald L Cowan
Journal:  Neuropsychopharmacology       Date:  2013-01       Impact factor: 7.853

6.  Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.

Authors:  T Schilt; M M L de Win; G Jager; M W Koeter; N F Ramsey; B Schmand; W van den Brink
Journal:  Psychol Med       Date:  2007-11-08       Impact factor: 7.723

7.  Neuroimaging in human MDMA (Ecstasy) users.

Authors:  Ronald L Cowan; Deanne M Roberts; James M Joers
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

Authors:  U D McCann; Z Szabo; U Scheffel; R F Dannals; G A Ricaurte
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

9.  Differential effects of D-amphetamine on red and blue light-induced photic activation: A novel BOLD fMRI assay of human dopamine function.

Authors:  Ronald L Cowan; Julia Wood; Mary S Dietrich; Blaise de B Frederick; Scott E Lukas; Perry F Renshaw
Journal:  Synapse       Date:  2008-04       Impact factor: 2.562

10.  Ecstasy and drug consumption patterns: a Canadian rave population study.

Authors:  Samantha R Gross; Sean P Barrett; John S Shestowsky; Robert O Pihl
Journal:  Can J Psychiatry       Date:  2002-08       Impact factor: 4.356

View more
  3 in total

1.  The New Classes of Synthetic Illicit Drugs Can Significantly Harm the Brain: A Neuro Imaging Perspective with Full Review of MRI Findings.

Authors:  S Creagh; D Warden; M A Latif; A Paydar
Journal:  Clin Radiol Imaging J       Date:  2018-04-25

2.  Sex differences in MDMA-induced toxicity in Sprague-Dawley rats.

Authors:  Sara Soleimani Asl; Mehdi Mehdizadeh; Soudabeh Hamedi Shahraki; Tayebeh Artimani; Mohammad Taghi Joghataei
Journal:  Funct Neurol       Date:  2015 Apr-Jun

3.  Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective.

Authors:  Kim P C Kuypers; Eef L Theunissen; Janelle H P van Wel; Elizabeth B de Sousa Fernandes Perna; Anke Linssen; Anke Sambeth; Benjamin G Schultz; Johannes G Ramaekers
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.